Paper Details

  1. Home
  2. Paper Details

Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity.

Author: BealM Flint, BrowneSusan E, CalingasanNoel Y, GardianGabrielle, KlivenyiPeter, SaydoffJoel, YangLichuan, von BorstelReid

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Overview

Triacetyluridine (TAU) is a drug that delivers pyrimidines to the brain, which may help to compensate for bioenergetic defects. Studies show that TAU may be a novel approach for treating neurodegenerative diseases, such as Parkinson’s disease.
Paper Details　
Original Abstract of the Article :
Administration of triacetyluridine (TAU) is a means of delivering exogenous pyrimidines to the brain, which may help to compensate for bioenergetic defects. TAU has previously been shown to be neuroprotective in animal models of Huntington's and Alzheimer's diseases. We examined whether oral adminis...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1385/NMM:6:2-3:087

データ提供：米国国立医学図書館（NLM）

Triacetyluridine: A Potential Neuroprotective Agent for Parkinson's Disease

Parkinson's disease, a neurodegenerative disorder that affects movement and coordination, is a challenging condition for patients and researchers alike. This study explores the potential of triacetyluridine (TAU), a compound that can be delivered to the brain to support energy production, as a neuroprotective agent against Parkinson's disease. The researchers investigated the effects of TAU in a mouse model of Parkinson's disease, specifically examining its impact on dopamine levels and neuronal loss in the brain. The study found that TAU significantly attenuated dopamine depletion and neuronal loss, suggesting that it may have potential as a therapeutic agent for Parkinson's disease.

Triacetyluridine: A Potential Neuroprotective Agent for Parkinson's Disease

This research suggests that triacetyluridine (TAU) may be a promising neuroprotective agent for Parkinson's disease. The study demonstrated that TAU, when administered orally, significantly attenuated dopamine depletion and neuronal loss in a mouse model of the disease. These findings highlight the potential of TAU as a therapeutic approach for Parkinson's disease, warranting further investigation.

Navigating the Desert of Neurodegeneration

Just as a camel navigates a challenging desert landscape, researchers are searching for ways to combat the harsh reality of neurodegenerative diseases. This study offers hope for Parkinson's disease patients, suggesting that TAU could potentially protect neurons and alleviate symptoms. It's like finding a hidden spring in a dry desert – the discovery of TAU's neuroprotective effects could be a significant step forward in the fight against Parkinson's disease.

Dr.Camel's Conclusion

This research offers a glimmer of hope for patients battling Parkinson's disease. The neuroprotective effects of triacetyluridine (TAU) suggest a potential new avenue for treatment. It's like finding a cool breeze in the scorching desert – TAU could provide much-needed relief and support for those affected by this challenging condition.

Date :
  1. Date Completed 2005-10-05
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

15970626

DOI: Digital Object Identifier

10.1385/NMM:6:2-3:087

Related Literature

Article Analysis
・Effects of uridine triacetate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.